The Journal of Immunology, Vol 144, Issue 12 4541-4547, Copyright © 1990 by American Association of Immunologists

ARTICLES

Ligand binding to the LFA-3 cell adhesion molecule induces IL-1 production by human thymic epithelial cells

PT Le, LW Vollger, BF Haynes and KH Singer
Department of Medicine, Duke University Medical Center, Durham, NC 27710.

We have shown that human thymic epithelial (TE) cells produce IL-1 alpha, IL-1 beta, and TE cells bind to thymocytes by CD2 and LFA-1 molecules on thymocytes and LFA-3, ICAM-1 on TE cells. We investigated whether ligand binding to LFA-3 on human TE cells can modulate TE cell IL-1 production. First, we investigated the ability of human thymocytes to regulate IL-1 release by TE cells. Both autologous and allogenic emetine-treated thymocytes when cultured with TE cells augmented IL-1 release by TE cells. The augmentation of IL-1 release was cell density dependent. Inasmuch as the interaction between thymocytes and TE cells is mediated in part by CD2 molecules on thymocytes and LFA-3 molecules on TE cells we next determined the effect on IL-1 release of ligand binding (anti-LFA-3 mAb TS2/9) to TE cell surface LFA-3. Purified anti- LFA-3 mAb augmented IL-1 release in a concentration-dependent fashion. The anti-LFA-3-mediated augmentation of IL-1 release required both new protein and RNA synthesis as shown by the ability of cycloheximide and actinomycin-D to inhibit augmentation of IL-1 production by TE cells, and by direct quantitation of IL-1 alpha and IL-1 beta mRNA by Northern blot analysis. Both F(ab)'2 and Fab' fragments of anti-LFA-3 mAb augmented IL-1 alpha and IL-1 beta mRNA production, indicating that monovalent binding to cell surface LFA-3 was sufficient to provide the inducing signal. The identification of LFA-3, the cell surface ligand for thymocyte CD2 molecules, as a molecule via which TE cell-derived cytokine production may be regulated suggests a mechanism at the cell surface by which direct TE cell-thymocyte interaction might result in the triggering of local IL-1 release within the human thymic microenvironment.

This article has been cited by other articles:

				C. Tenca, A. Merlo, D. Zarcone, D. Saverino, S. Bruno, A. De Santanna, D. Ramarli, M. Fabbi, C. Pesce, S. Deaglio, et al. Death of T cell precursors in the human thymus: a role for CD38 Int. Immunol., September 1, 2003; 15(9): 1105 - 1116. [Abstract] [Full Text] [PDF]

				N. G. Singer, D. A. Fox, T. M. Haqqi, L. Beretta, J. S. Endres, S. Prohaska, J. R. Parnes, J. Bromberg, and R. M. Sramkoski CD6: expression during development, apoptosis and selection of human and mouse thymocytes Int. Immunol., June 1, 2002; 14(6): 585 - 597. [Abstract] [Full Text] [PDF]

				G. D. Sempowski, L. P. Hale, J. S. Sundy, J. M. Massey, R. A. Koup, D. C. Douek, D. D. Patel, and B. F. Haynes Leukemia Inhibitory Factor, Oncostatin M, IL-6, and Stem Cell Factor mRNA Expression in Human Thymus Increases with Age and Is Associated with Thymic Atrophy J. Immunol., February 15, 2000; 164(4): 2180 - 2187. [Abstract] [Full Text] [PDF]

				Y. Mazaki, H. Uchida, O. Hino, S. Hashimoto, and H. Sabe Paxillin Isoforms in Mouse. LACK OF THE gamma  ISOFORM AND DEVELOPMENTALLY SPECIFIC beta  ISOFORM EXPRESSION J. Biol. Chem., August 28, 1998; 273(35): 22435 - 22441. [Abstract] [Full Text] [PDF]

				M. Rothe, L. Chene, M.-T. Nugeyre, J. Braun, F. Barre-Sinoussi, and N. Israel Contact with Thymic Epithelial Cells as a Prerequisite for Cytokine-Enhanced Human Immunodeficiency Virus Type 1 Replication in Thymocytes J. Virol., July 1, 1998; 72(7): 5852 - 5861. [Abstract] [Full Text] [PDF]

				D. Itzhaky, N. Raz, and N. Hollander The Glycosylphosphatidylinositol-Anchored Form and the Transmembrane Form of CD58 Associate with Protein Kinases J. Immunol., May 1, 1998; 160(9): 4361 - 4366. [Abstract] [Full Text] [PDF]

				I Screpanti, A Modesti, and A Gulino Heterogeneity of thymic stromal cells and thymocyte differentiation: a cell culture approach J. Cell Sci., January 7, 1993; 105(3): 601 - 606. [PDF]

				W. Hahn, E Menu, A. Bothwell, P. Sims, and B. Bierer Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59 Science, June 26, 1992; 256(5065): 1805 - 1807. [Abstract] [PDF]